RET kinase inhibitor
orally efficacious in XG but narrow TI
from data mining of internal matter and opt.
ACS Med. Chem. Lett. Feb. 12, 2020
Novartis (GNF), San Diego, CA
WF-47-JS03
1 min read
(Novartis (GNF) oral in vivo RET kinase inhibitor)
Search By Structure
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- “compound 25”
- “compound 25”-2
- WF-47-JS03
- BMS-986260
- GNF2133
Molecules of the Month
2023
2022
2021
2020